Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rituxan, Ifosfamide, Mitoxantrone and Etoposide with Filgrastim Support, for induction and stem cell mobilization prior to HDC in patients with B-cell Non-Hodgkin’s Lymphoma

Rituxan, Ifosfamide, Mitoxantrone and Etoposide with Filgrastim Support, for induction and stem cell mobilization prior to HDC in patients with B-cell Non-Hodgkin’s Lymphoma. Proceedings of ASBMT. 2000.


© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.